Literature DB >> 19286808

Identification and characterization of a novel multidrug resistance operon, mdtRP (yusOP), of Bacillus subtilis.

Ji-Yun Kim1, Takashi Inaoka, Kazutaka Hirooka, Hiroshi Matsuoka, Makiko Murata, Reiko Ohki, Yoshikazu Adachi, Yasutaro Fujita, Kozo Ochi.   

Abstract

Using comparative genome sequencing analysis, we identified a novel mutation in Bacillus subtilis that confers a low level of resistance to fusidic acid. This mutation was located in the mdtR (formerly yusO) gene, which encodes a MarR-type transcriptional regulator, and conferred a low level of resistance to several antibiotics, including novobiocin, streptomycin, and actinomycin D. Transformation experiments showed that this mdtR mutation was responsible for multidrug resistance. Northern blot analysis revealed that the downstream gene mdtP (formerly yusP), which encodes a multidrug efflux transporter, is cotranscribed with mdtR as an operon. Disruption of the mdtP gene completely abolished the multidrug resistance phenotype observed in the mdtR mutant. DNase I footprinting and primer extension analyses demonstrated that the MdtR protein binds directly to the mdtRP promoter, thus leading to repression of its transcription. Moreover, gel mobility shift analysis indicated that an Arg83 --> Lys or Ala67 --> Thr substitution in MdtR significantly reduces binding affinity to DNA, resulting in derepression of mdtRP transcription. Low concentrations of fusidic acid induced the expression of mdtP, although the level of mdtP expression was much lower than that in the mdtR disruptant. These findings indicate that the MdtR protein is a repressor of the mdtRP operon and that the MdtP protein functions as a multidrug efflux transporter in B. subtilis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286808      PMCID: PMC2687175          DOI: 10.1128/JB.00151-09

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

1.  Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding.

Authors:  M N Alekshun; Y S Kim; S B Levy
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

2.  Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site.

Authors:  M Laurberg; O Kristensen; K Martemyanov; A T Gudkov; I Nagaev; D Hughes; A Liljas
Journal:  J Mol Biol       Date:  2000-11-03       Impact factor: 5.469

3.  The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution.

Authors:  M N Alekshun; S B Levy; T R Mealy; B A Seaton; J F Head
Journal:  Nat Struct Biol       Date:  2001-08

4.  Essential Bacillus subtilis genes.

Authors:  K Kobayashi; S D Ehrlich; A Albertini; G Amati; K K Andersen; M Arnaud; K Asai; S Ashikaga; S Aymerich; P Bessieres; F Boland; S C Brignell; S Bron; K Bunai; J Chapuis; L C Christiansen; A Danchin; M Débarbouille; E Dervyn; E Deuerling; K Devine; S K Devine; O Dreesen; J Errington; S Fillinger; S J Foster; Y Fujita; A Galizzi; R Gardan; C Eschevins; T Fukushima; K Haga; C R Harwood; M Hecker; D Hosoya; M F Hullo; H Kakeshita; D Karamata; Y Kasahara; F Kawamura; K Koga; P Koski; R Kuwana; D Imamura; M Ishimaru; S Ishikawa; I Ishio; D Le Coq; A Masson; C Mauël; R Meima; R P Mellado; A Moir; S Moriya; E Nagakawa; H Nanamiya; S Nakai; P Nygaard; M Ogura; T Ohanan; M O'Reilly; M O'Rourke; Z Pragai; H M Pooley; G Rapoport; J P Rawlins; L A Rivas; C Rivolta; A Sadaie; Y Sadaie; M Sarvas; T Sato; H H Saxild; E Scanlan; W Schumann; J F M L Seegers; J Sekiguchi; A Sekowska; S J Séror; M Simon; P Stragier; R Studer; H Takamatsu; T Tanaka; M Takeuchi; H B Thomaides; V Vagner; J M van Dijl; K Watabe; A Wipat; H Yamamoto; M Yamamoto; Y Yamamoto; K Yamane; K Yata; K Yoshida; H Yoshikawa; U Zuber; N Ogasawara
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

5.  An aberrant protein synthesis activity is linked with antibiotic overproduction in rpsL mutants of Streptomyces coelicolor A3(2).

Authors:  Yoshiko Okamoto-Hosoya; Takeshi Hosaka; Kozo Ochi
Journal:  Microbiology (Reading)       Date:  2003-11       Impact factor: 2.777

6.  Combined transcriptome and proteome analysis as a powerful approach to study genes under glucose repression in Bacillus subtilis.

Authors:  K Yoshida ; K Kobayashi; Y Miwa; C M Kang; M Matsunaga; H Yamaguchi; S Tojo; M Yamamoto; R Nishi; N Ogasawara; T Nakayama; Y Fujita
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

7.  Enhancement of glutamine utilization in Bacillus subtilis through the GlnK-GlnL two-component regulatory system.

Authors:  Takenori Satomura; Daisuke Shimura; Kei Asai; Yoshito Sadaie; Kazutake Hirooka; Yasutaro Fujita
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

8.  Construction of an in vivo nonsense readthrough assay system and functional analysis of ribosomal proteins S12, S4, and S5 in Bacillus subtilis.

Authors:  T Inaoka; K Kasai; K Ochi
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

9.  Guanine nucleotides guanosine 5'-diphosphate 3'-diphosphate and GTP co-operatively regulate the production of an antibiotic bacilysin in Bacillus subtilis.

Authors:  Takashi Inaoka; Kosaku Takahashi; Mayumi Ohnishi-Kameyama; Mitsuru Yoshida; Kozo Ochi
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

10.  Molecular analysis of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

View more
  9 in total

1.  LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule.

Authors:  Fernando A Pagliai; Christopher L Gardner; Santosh G Pande; Graciela L Lorca
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

3.  Scandium stimulates the production of amylase and bacilysin in Bacillus subtilis.

Authors:  Takashi Inaoka; Kozo Ochi
Journal:  Appl Environ Microbiol       Date:  2011-09-23       Impact factor: 4.792

4.  The Bacillus subtilis tyrZ gene encodes a highly selective tyrosyl-tRNA synthetase and is regulated by a MarR regulator and T box riboswitch.

Authors:  Rebecca N Williams-Wagner; Frank J Grundy; Medha Raina; Michael Ibba; Tina M Henkin
Journal:  J Bacteriol       Date:  2015-03-02       Impact factor: 3.490

5.  Impact of activation of neotrehalosadiamine/kanosamine biosynthetic pathway on the metabolism of Bacillus subtilis.

Authors:  Natsumi Saito; Huong Minh Nguyen; Takashi Inaoka
Journal:  J Bacteriol       Date:  2021-02-22       Impact factor: 3.490

6.  ScoC regulates bacilysin production at the transcription level in Bacillus subtilis.

Authors:  Takashi Inaoka; Guojun Wang; Kozo Ochi
Journal:  J Bacteriol       Date:  2009-10-02       Impact factor: 3.490

7.  Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.

Authors:  Sanath Kumar; Mun Mun Mukherjee; Manuel F Varela
Journal:  Int J Bacteriol       Date:  2013

8.  Bacterial diversity and the antimicrobial resistome in the southwestern highlands of Saudi Arabia.

Authors:  Muhammad Yasir; Raees Khan; Riaz Ullah; Fehmida Bibi; Imran Khan; Asad Mustafa Karim; Ahmed K Al-Ghamdi; Esam I Azhar
Journal:  Saudi J Biol Sci       Date:  2021-11-24       Impact factor: 4.052

9.  Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.

Authors:  Arnau Vich Vila; Valerie Collij; Serena Sanna; Trishla Sinha; Floris Imhann; Arno R Bourgonje; Zlatan Mujagic; Daisy M A E Jonkers; Ad A M Masclee; Jingyuan Fu; Alexander Kurilshikov; Cisca Wijmenga; Alexandra Zhernakova; Rinse K Weersma
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.